Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

PHASE3CompletedINTERVENTIONAL
Enrollment

637

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Primary Insomnia
Interventions
DRUG

Eplivanserin

one 5 mg tablet once a day

DRUG

Placebo

Placebo of Eplivanserin one tablet once a day

Trial Locations (7)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Vienna

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Budapest

Sanofi-Aventis Administrative Office, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY